Current position:Home >Product >
N-[3-(dimethylamino)phenyl]-2-[4-(8-methyl-2-oxidanylidene-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]ethanamide
N-[3-(dimethylamino)phenyl]-2-[4-(8-methyl-2-oxidanylidene-4H-3,1-benzoxazin-1-yl)piperidin-1-yl]ethanamide
|
|
Canonical SMILES:
CC1=CC=CC2=C1N(C(=O)OC2)C3CCN(CC3)CC(=O)NC4=CC(=CC=C4)N(C)C
Isomeric SMILES
CC1=CC=CC2=C1N(C(=O)OC2)C3CCN(CC3)CC(=O)NC4=CC(=CC=C4)N(C)C
InChI
InChI=1S/C24H30N4O3/c1-17-6-4-7-18-16-31-24(30)28(23(17)18)20-10-12-27(13-11-20)15-22(29)25-19-8-5-9-21(14-19)26(2)3/h4-9,14,20H,10-13,15-16H2,1-3H3,(H,25,29)
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- [(2R,3S,4R,6S)-3-acetyloxy-6-ethoxy-2-[(E)-4-phenylsulfanylbut-2-enyl]oxan-4-yl]methyl ethanoate
- [(6Z,13S)-13-ethyl-2-methoxy-6-methoxyimino-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-3-yl] sulfamate
- 2-(12-quinolin-2-yldodecyl)quinoline
- 9-[tert-butyl(diphenyl)silyl]oxy-4-methyl-nona-2,3-diene-1,5-diol
- methyl 3-[[6-[[tert-butyl(dimethyl)silyl]oxymethyl]-1,2-dithiin-3-yl]methoxy]benzoate
- (1R,3aR,5aS,5bR,7aS,8S,11aS,11bR,13aS,13bR)-3a,5b,8,11a-tetramethyl-9-oxidanylidene-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,8,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-5a-carbaldehyde
- (5S,6Z,8E,10E)-11-[2-[(Z)-oct-2-enyl]-1,3-dithian-2-yl]-5-oxidanyl-undeca-6,8,10-trienoic acid
- (3R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bS)-5a,5b,8,8,11a,13b-hexamethyl-3-prop-1-en-2-yl-2,3,3a,4,5,6,7,7a,10,11,11b,12,13,13a-tetradecahydro-1H-cyclopenta[a]chrysen-9-one
- (8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-7-propyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
- (E)-3-[2-butyl-3-[(2-chlorophenyl)methyl]imidazol-4-yl]-2-(4-methoxyphenyl)prop-2-enoic acid

